Cinar AB, Schou L Interrelation between patient satisfaction and patient-provider communication in diabetes management. ScientificWorldJournal. 2014;2014:372671. doi: 10.1155/2014/372671. Epub 2014 Dec 28.
Kinmonth AL, Spiegal N, Woodcock A Developing a training programme in patient-centred consulting for evaluation in a randomised controlled trial; diabetes care from diagnosis in British primary care. Patient Educ Couns. 1996 Oct;29(1):75-86.
Mira Solves JJ, Guilabert M, Pérez-Jover V La medida de la experiencia del paciente en el contexto de una atención centrada en el propio paciente. Rev Española Med Prev y Salud Pública. 2018;XXIII:5-11.
OMS Informe mundial sobre la Diabetes. Organización Mundial de la Salud. 2016.
Porter M, Lee TH The strategy that will fix health care. Harvard Business Review. 2013;94:24.
Prieto Rodríguez MA, March Cerdá JC [Step by step in the design of a focus group-based study]. Aten Primaria. 2002 Apr 15;29(6):366-73. Review. Spanish.
Shah A Value-based healthcare: A global assessment. Econ Intell Unit. 2016;32
Svedbo Engström M, Leksell J, Johansson UB, Gudbjörnsdottir S What is important for you? A qualitative interview study of living with diabetes and experiences of diabetes care to establish a basis for a tailored Patient-Reported Outcome Measure for the Swedish National Diabetes Register. BMJ Open. 2016 Mar 24;6(3):e010249. doi: 10.1136/bmjopen-2015-010249.
Patient Centered Care in Diabetes in Ecuador: Mixed-methods Study.
Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.
Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.
Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.
Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.
Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.
